Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Study to Investigate the Safety and Pharmacokinetics of SK3530 Tablet in Renal Impaired Male Patients (SK3530_RI_I)

This study has been completed.
SK Chemicals Co.,Ltd.
Information provided by (Responsible Party):
Kyun-Seop Bae, Asan Medical Center Identifier:
First received: November 1, 2010
Last updated: January 13, 2015
Last verified: January 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2011 (Final data collection date for primary outcome measure)